Martin Lee @ Sg
Sharing is Caring!

Hyflux Townhall Meeting and SIAS Briefing

Hyflux will be organizing their third townhall session with their investors. This will be a combined event for all Notes, Preference Shares and Perpetual Securities investors.

Date : 13 March 2019 (Wednesday)
Time : 7pm
Venue : Hyflux Innovation Centre, MPH, 80 Bendemeer Road, Singapore 339949

To attend, please register here by 12pm on Friday, 8 March 2019:

https://www.hyflux.com/financial-reorganisation-exercise/shareholders-and-holders-of-securities

A holder of Securities who holds such Securities through nominees (including, if such holder is a corporation, its appointed representative) must present its proof of holdings or letter of verification in order to gain entry to the Third Round of Town Hall Meetings.

Separately SIAS is holding a series of briefings for investors this week. The sessions for the Preference Shares and Perpetual Securities are already full booked so I will just post details of the sessions for the Notes holders.

Venue: FTI Consulting, 8 Shenton Way, #32-03, AXA Tower, Singapore 068811

Date: 5 March 2019 (Tuesday)
Time: 12pm to 2pm

Register here.

Date: 5 March 2019 (Tuesday)
Time: 630pm to 830pm

Register here.

Date: 6 March 2019 (Wednesday)
Time: 12pm to 2pm

Register here.

Petition to Singapore Government to Save Hyflux’s Investors

Click here to view and sign the petition

Contacting other Hyflux Investors

if you are an investor of Hyflux who wish to connect with other investors, there are two options listed below. Most of the people in these groups are preference shares, perpetual securities or note holders. The equity investors are mostly quiet for now.

1) Telegram chat group : https://t.me/hyflux_retail

2) Email mailing list currently maintained by me. This serves as an notification of Hyflux news as well as discussion among the members (ie all members can broadcast to the list). If you want to join the group, please fill in the form below and you will be added within 24 hours:

Leave a Comment: